Cargando…

Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma

Background: Exosomes play a crucial role in tumor initiation and progression, yet the precise involvement of exosome-related genes (ERGs) in lung adenocarcinoma (LUAD) remains unclear. Methods: We conducted a comprehensive investigation of ERGs within the tumor microenvironment (TME) of LUAD using s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Shengrong, Zhou, Shengjie, Han, Xin, Yang, Yang, Zhou, Hao, Chang, Xuejiao, Zhou, Yefeng, Ding, Yuqin, Lin, Huihui, Hu, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637798/ https://www.ncbi.nlm.nih.gov/pubmed/37878007 http://dx.doi.org/10.18632/aging.205140

Ejemplares similares

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

DC-Derived Exosomes for Cancer Immunotherapy
por: Yao, Yi, et al.
Publicado: (2021)

Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma
por: Wang, Cheng, et al.
Publicado: (2021)

Expression of Glypican 3 Is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes
por: Rahbari, Mohammad, et al.
Publicado: (2019)

The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
por: Hsu, Sheng-Kai, et al.
Publicado: (2023)

Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2022)

Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
por: Wang, Xia, et al.
Publicado: (2022)

Novel exosome-related risk signature as prognostic biomarkers in glioblastoma
por: Ding, Mingyan, et al.
Publicado: (2023)

Immune-related risk prognostic model for clear cell renal cell carcinoma: Implications for immunotherapy
por: Chen, Ronghui, et al.
Publicado: (2023)

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
por: Huang, Yong, et al.
Publicado: (2022)

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma
por: Zhang, Peng, et al.
Publicado: (2022)

Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers
por: Sun, Sijin, et al.
Publicado: (2021)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
por: Wang, Yizhi, et al.
Publicado: (2020)

A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2022)

ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
por: Zheng, Yu-Zhu, et al.
Publicado: (2016)

Serum Nardilysin as a Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
por: Xu, Yongfeng, et al.
Publicado: (2022)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Screening microRNAs as potential prognostic biomarkers for lung adenocarcinoma
por: Dai, Hongshuang, et al.
Publicado: (2023)

Exosome reporter mice reveal the involvement of exosomes in mediating neuron to astroglia communication in the CNS
por: Men, Yuqin, et al.
Publicado: (2019)

Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Ting, et al.
Publicado: (2021)

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy
por: Varn, Frederick S., et al.
Publicado: (2018)

Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer
por: Xu, Hao, et al.
Publicado: (2020)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

Plasma Exosomal miRNA Expression Profile as Oxaliplatin-Based Chemoresistant Biomarkers in Colorectal Adenocarcinoma
por: Han, Jiayi, et al.
Publicado: (2020)

Metabolomics of cerebrospinal fluid reveals prognostic biomarkers in pediatric status epilepticus
por: Wang, Tianqi, et al.
Publicado: (2023)

Prognostic significance of pyroptosis-related factors in lung adenocarcinoma
por: Lin, Ximing, et al.
Publicado: (2022)

Integrative analysis of exosomal microRNA-149-5p in lung adenocarcinoma
por: Tian, Wen, et al.
Publicado: (2021)

Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers
por: Li, Rui, et al.
Publicado: (2019)

SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma
por: Yuan, Lu, et al.
Publicado: (2021)

Construction and Characterization of Long Non-Coding RNA-Associated Networks to Reveal Potential Prognostic Biomarkers in Human Lung Adenocarcinoma
por: Zhou, Wenting, et al.
Publicado: (2021)

Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy
por: Huang, Fuxue, et al.
Publicado: (2022)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

ASF1B acted as a prognostic biomarker for stomach adenocarcinoma
por: Zhao, Cailing, et al.
Publicado: (2023)

Mutational landscape of SWI/SNF complex genes reveal correlation to predictive biomarkers for immunotherapy sensitivity in lung adenocarcinoma patients
por: Xu, H., et al.
Publicado: (2023)

The tumor microenvironment in gastrointestinal adenocarcinomas revealed a prognostic and immunotherapeutic biomarker
por: Zhang, Yong, et al.
Publicado: (2022)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
por: Liu, Bo, et al.
Publicado: (2021)

Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
por: Zhao, Jian-Gang, et al.
Publicado: (2023)

Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS metabolomics
por: Mo, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ngfsn6udirro60j0kb3bu7hkno